SUR7 Antibody

What is Sur7 protein and why is it significant for fungal pathogen research?

Sur7 is a tetraspan membrane protein found in Candida albicans that displays amino acid similarity to the claudin family of proteins in animals . It is localized in plasma membrane MCC/eisosome domains and plays a critical role in regulating multiple cellular processes essential for fungal virulence. Sur7 mediates normal cell wall morphogenesis and stress resistance in C. albicans, which are crucial for its ability to cause systemic infections . The significance of Sur7 stems from its novel role as a regulator of phosphatidylinositol 4,5-bisphosphate (PI4,5P2), a plasma membrane lipid critical for proper cellular signaling and morphogenesis . Researchers use SUR7 antibody to investigate these regulatory mechanisms and to understand how Sur7 influences C. albicans pathogenicity.

What cellular functions does Sur7 regulate in C. albicans?

Sur7 regulates multiple essential cellular functions in C. albicans including:

• Cell wall morphogenesis - Critical for invasive hyphal growth and avoiding immune detection

• Plasma membrane architecture - Maintains phospholipid asymmetry

• Stress resistance - Mediates resistance to cell wall and plasma membrane stressors

• PI4,5P2 regulation - Controls the distribution and function of this signaling lipid

• Septin protein localization - Prevents ectopic septin localization that leads to abnormal cell wall growth

The sur7Δ mutant displays increased sensitivity to copper and duramycin, indicating abnormal presence of phosphatidylserine and phosphatidylethanolamine in the outer leaflet of the plasma membrane . Sur7 also indirectly controls plasma membrane asymmetry through its regulation of PI4,5P2 . The protein's broad impact on cellular functions makes it a valuable target for antifungal research.

What methodological approaches can be used to detect Sur7 localization?

To detect Sur7 localization in C. albicans, researchers can employ multiple complementary techniques:

• Immunofluorescence microscopy: Using SUR7 antibody with fluorescent secondary antibodies to visualize the protein's distribution in fixed cells. This allows visualization of Sur7's characteristic pattern in MCC/eisosome domains.

• GFP-tagging: Creating Sur7-GFP fusion constructs to monitor protein localization in live cells, which enables dynamic studies of Sur7 movement during cell growth and stress response.

• Co-localization studies: Combined with markers for PI4,5P2 (such as the PLCδ1 PH domain probe) to analyze the relationship between Sur7 and this phospholipid .

• Subcellular fractionation: Using SUR7 antibody in western blot analysis of different cellular fractions to biochemically confirm membrane localization.

When performing these analyses, it's critical to include appropriate controls, particularly sur7Δ mutant strains to confirm antibody specificity and to establish baseline fluorescence levels.

How can SUR7 antibody be used to investigate the relationship between Sur7 and PI4,5P2 regulation?

SUR7 antibody can be instrumental in elucidating the mechanistic relationship between Sur7 and PI4,5P2 regulation through several sophisticated experimental approaches:

• Co-immunoprecipitation assays: Using SUR7 antibody to pull down Sur7 and its interacting partners, followed by proteomics analysis to identify proteins involved in PI4,5P2 metabolism that directly interact with Sur7.

• Proximity labeling techniques: Combining SUR7 antibody with BioID or APEX2 proximity labeling to identify proteins in close proximity to Sur7 in living cells, potentially revealing transient interactions with PI4,5P2 regulatory enzymes.

• Immunofluorescence co-localization: Performing dual labeling with SUR7 antibody and PI4,5P2 markers (like the PLCδ1 PH domain) to quantitatively assess spatial relationships between Sur7 and PI4,5P2 patches .

• Chromatin immunoprecipitation (ChIP): If Sur7 affects transcriptional regulation of PI4,5P2 metabolic enzymes, ChIP using transcription factor antibodies combined with Sur7 manipulation can reveal indirect regulatory mechanisms.

Recent research has demonstrated that sur7Δ mutants display abnormal clusters of PI4,5P2, and this phenotype can be rescued by deleting one copy of MSS4, the gene encoding the kinase that produces PI4,5P2 . This indicates that Sur7 negatively regulates PI4,5P2 levels, possibly by influencing the activity or localization of PI4,5P2 phosphatases like Inp51, Inp52, and Inp54 .

What experimental approaches can assess the role of Sur7 in cell wall morphogenesis?

Researchers investigating Sur7's role in cell wall morphogenesis can employ these methodological approaches using SUR7 antibody:

• Transmission electron microscopy (TEM): Combined with immunogold labeling using SUR7 antibody to correlate Sur7 localization with cell wall architecture at ultrastructural resolution .

• Cell wall composition analysis: Compare wild-type and sur7Δ strains using specific stains (e.g., Calcofluor White for chitin) in conjunction with SUR7 antibody to correlate Sur7 presence with cell wall component distribution.

• Time-lapse microscopy: Using fluorescently labeled SUR7 antibody fragments in live cell imaging to track dynamic changes in Sur7 localization during cell wall remodeling and growth.

• Conditional expression systems: Combining with SUR7 antibody to detect Sur7 levels when modulating its expression, allowing correlation between protein levels and morphogenesis phenotypes.

Studies have shown that abnormal cell wall invaginations in sur7Δ mutants are associated with patches of PI4,5P2 that recruit septin proteins like Cdc10 . These septins act as scaffolds for cell wall synthesis machinery, including chitin synthases like Chs3 . The mechanistic pathway appears to be: Sur7 → PI4,5P2 regulation → septin localization → chitin deposition → cell wall morphogenesis.

How can SUR7 antibody be used to study the relationship between Sur7 and septin proteins?

The relationship between Sur7 and septin proteins can be investigated using SUR7 antibody through several sophisticated approaches:

• Co-immunoprecipitation studies: Using SUR7 antibody to pull down Sur7 complexes followed by western blotting for septin proteins (Cdc10, Cdc12) to detect physical interactions or membership in the same protein complexes.

• Sequential immunofluorescence: Performing double-labeling experiments with SUR7 antibody and septin antibodies to analyze their spatial relationship, particularly at sites of abnormal cell wall growth in sur7Δ mutants.

• Proximity ligation assay (PLA): Combining SUR7 antibody with septin antibodies in PLA to detect close proximity (<40 nm) between these proteins in situ, providing evidence for functional complexes.

• Immunofluorescence in genetic backgrounds: Analyzing septin localization using SUR7 antibody in strains with altered PI4,5P2 levels (e.g., inp51Δ inp52Δ mutants) to establish the causal chain from Sur7 to PI4,5P2 to septin mislocalization.

Research has shown that in sur7Δ cells, septins like Cdc10 mislocalize to PI4,5P2 patches rather than being exclusively found at the bud neck . Destabilizing septins in sur7Δ strains by mutating CDC10 or CDC12 reduced the abnormal cell wall phenotype, supporting a direct role for septins in mediating the effects of Sur7 deletion .

What techniques can be used to validate SUR7 antibody specificity in experimental studies?

Validating SUR7 antibody specificity is critical for research integrity. Researchers should employ multiple complementary approaches:

• Western blot analysis:

  • Compare protein detection in wild-type vs. sur7Δ mutant strains

  • Analyze size-specific band patterns matching Sur7's predicted molecular weight

  • Include epitope-tagged Sur7 constructs as positive controls

• Immunofluorescence controls:

  • Parallel staining of wild-type and sur7Δ cells

  • Peptide competition assays where the antibody is pre-incubated with purified Sur7 peptide

  • Secondary antibody-only controls to assess non-specific binding

• Genetic complementation:

  • Reintroducing SUR7 into sur7Δ mutants should restore antibody recognition patterns

  • Using strains with regulated SUR7 expression to demonstrate signal correlation with expression levels

• Mass spectrometry validation:

  • Immunoprecipitate with SUR7 antibody and confirm identity of pulled-down proteins via mass spectrometry

  • Compare peptide coverage maps with Sur7's known sequence

Given Sur7's multiple roles in C. albicans physiology, proper antibody validation ensures that observed phenotypes can be correctly attributed to Sur7 function rather than potential cross-reactivity with other tetraspan membrane proteins.

How can researchers use SUR7 antibody to investigate stress response mechanisms in C. albicans?

SUR7 antibody can be leveraged to study stress response mechanisms through these methodological approaches:

• Stress-induced relocalization studies:

  • Track Sur7 distribution using SUR7 antibody before and after exposure to stressors

  • Quantify changes in Sur7 localization patterns during copper, duramycin, or cell wall stress

• Co-immunoprecipitation under stress conditions:

  • Use SUR7 antibody to pull down protein complexes under different stress conditions

  • Identify stress-specific interaction partners that may mediate resistance mechanisms

• Phosphorylation state analysis:

  • Combine SUR7 antibody immunoprecipitation with phospho-specific detection methods

  • Determine if Sur7's phosphorylation state changes during stress, potentially altering its function

• Chromatin immunoprecipitation (ChIP)-sequencing:

  • If Sur7 affects transcriptional responses, use transcription factor antibodies in wild-type vs. sur7Δ backgrounds

  • Map genome-wide transcriptional changes in stress response pathways dependent on Sur7

Research has shown that both sur7Δ and inpΔ mutants display increased sensitivity to copper and duramycin, revealing the plasma membrane's altered architecture . Copper binds phosphatidylserine with high affinity, while duramycin binds phosphatidylethanolamine, both of which are normally enriched in the inner leaflet of the plasma membrane . The common phenotypes between these mutants indicate that Sur7's role in stress resistance is mediated through its regulation of PI4,5P2 and subsequent effects on membrane asymmetry.

What factors should researchers consider when using SUR7 antibody in different experimental models?

When applying SUR7 antibody across different experimental models, researchers should consider several critical factors:

• Species and strain specificity:

  • Sur7 shares structural features with claudin proteins in animals but may have sequence variations across fungal species

  • Test cross-reactivity when using antibodies developed against Sur7 from one species to detect homologs in other fungi

  • Consider epitope conservation when studying Sur7 in non-C. albicans species

• Expression level variations:

  • Sur7 expression may vary under different growth conditions or developmental stages

  • Optimize antibody concentration for each experimental condition

  • Include appropriate loading controls when comparing Sur7 levels across conditions

• Fixation and permeabilization methods:

  • Sur7's membrane localization requires careful optimization of cell fixation protocols

  • Test multiple membrane permeabilization methods to ensure epitope accessibility

  • Consider native protein conformation preservation for certain applications

• Genetic background effects:

  • The effect of Sur7 deletion may vary depending on strain background

  • Include multiple strain backgrounds when possible to ensure observed phenotypes are generalizable

  • Consider compensatory mechanisms that may develop in sur7Δ strains during propagation

Researchers should validate the SUR7 antibody in each new experimental system to ensure reliable and reproducible results, especially when exploring Sur7's complex roles in regulating PI4,5P2, cell wall morphogenesis, and stress response pathways.

How can SUR7 antibody be used to investigate the relationship between Sur7 and virulence in C. albicans?

SUR7 antibody provides valuable tools for investigating the relationship between Sur7 and C. albicans virulence through several methodological approaches:

• Infection model analyses:

  • Use SUR7 antibody to monitor Sur7 expression and localization during infection in animal models

  • Compare Sur7 distribution in commensal versus invasive growth phases

  • Assess Sur7 levels in clinical isolates with varying virulence capabilities

• Host-pathogen interaction studies:

  • Apply SUR7 antibody in co-culture experiments with host immune cells

  • Determine if Sur7 relocalization occurs during phagocytosis

  • Investigate Sur7's role in evading immune recognition

• Phenotypic switching analysis:

  • Monitor Sur7 distribution during yeast-to-hyphal transitions using SUR7 antibody

  • Correlate Sur7 localization patterns with changes in cell wall architecture during morphogenesis

  • Assess the impact of environmental signals on Sur7 distribution and function

• In vivo expression profiling:

  • Recover C. albicans from infected tissues and analyze Sur7 expression compared to in vitro growth

  • Use SUR7 antibody to track protein levels during different stages of infection

Research has demonstrated that Sur7 plays critical roles in guiding C. albicans cell wall morphogenesis, which is important for invasive hyphal growth and avoiding immune detection . Sur7 also mediates resistance to copper, which is important for survival in macrophages . The broad impact of Sur7 on cellular properties stems from its regulation of PI4,5P2, making this relationship central to understanding virulence mechanisms.

What statistical approaches are recommended for analyzing SUR7 antibody localization data?

• Quantitative colocalization analysis:

  • Calculate Pearson's or Mander's correlation coefficients to measure colocalization between Sur7 and other markers

  • Employ Costes randomization to establish statistical significance of colocalization

  • Use object-based colocalization analysis for discrete structures like eisosomes

• Distribution pattern analysis:

  • Apply nearest neighbor distance analysis to quantify Sur7 clustering

  • Use Ripley's K-function to characterize spatial distribution patterns

  • Implement density-based spatial clustering algorithms to identify significant Sur7 accumulations

• Time-series analysis for dynamic studies:

  • Apply autocorrelation analysis to measure temporal stability of Sur7 structures

  • Use kymograph analysis to track Sur7 movement over time

  • Implement mean square displacement analysis for quantifying Sur7 mobility

• Comparison across experimental conditions:

  • Use appropriate statistical tests (t-test, ANOVA, etc.) based on data distribution

  • Apply multiple comparison corrections when analyzing Sur7 across numerous conditions

  • Consider hierarchical or mixed-effects models when analyzing nested experimental designs

When interpreting these analyses, researchers should consider that abnormal PI4,5P2 patches in sur7Δ mutants show a patchy distribution rather than even distribution around the plasma membrane , suggesting that quantitative analysis of distribution patterns may reveal important insights into Sur7 function.

How should researchers interpret contradictory findings regarding Sur7 function?

When encountering contradictory findings regarding Sur7 function, researchers should employ a systematic approach to interpretation:

• Methodology assessment:

  • Compare experimental approaches used in different studies (antibody specificity, fixation methods, microscopy techniques)

  • Evaluate whether differences in strain backgrounds might explain contradictory results

  • Consider whether growth conditions or media composition differences might influence Sur7 function

• Temporal considerations:

  • Assess whether contradictions might result from examining different time points in cellular processes

  • Determine if Sur7 might have different functions at different stages of growth or stress response

  • Consider whether short-term versus long-term phenotypes might differ due to compensatory mechanisms

• Multi-faceted functional analysis:

  • Recognize that Sur7 has multiple cellular roles as a PI4,5P2 regulator, cell wall morphogenesis factor, and stress response mediator

  • Consider whether seemingly contradictory findings might reflect different aspects of Sur7's multifunctional nature

  • Integrate findings into comprehensive models that account for Sur7's diverse effects

• Genetic interaction context:

  • Evaluate whether contradictory findings might result from different genetic backgrounds or interactions

  • Consider synthetic interactions where Sur7 phenotypes might be enhanced or suppressed by other mutations

  • Explore whether redundant pathways might mask Sur7 functions in certain genetic contexts

The diverse phenotypes observed in sur7Δ mutants emerge because Sur7 regulates PI4,5P2, a plasma membrane lipid critical for proper cellular signaling and morphogenesis . This regulatory relationship allows Sur7 to impact numerous cellular processes, potentially explaining seemingly contradictory findings in different experimental contexts.

What emerging technologies might enhance SUR7 antibody applications in fungal research?

Several emerging technologies hold promise for advancing SUR7 antibody applications in fungal research:

• Super-resolution microscopy techniques:

  • Stimulated emission depletion (STED) microscopy to resolve Sur7 distribution within eisosomes below the diffraction limit

  • Single-molecule localization microscopy (PALM/STORM) to map precise Sur7 organization at nanoscale resolution

  • Expansion microscopy to physically enlarge samples for improved visualization of Sur7 complexes

• Advanced protein interaction methods:

  • Split-protein complementation assays combined with SUR7 antibody validation to study dynamic protein interactions

  • Förster resonance energy transfer (FRET) between labeled SUR7 antibody fragments and potential interaction partners

  • Cross-linking mass spectrometry to capture transient interactions in the Sur7 interactome

• Genome editing technologies:

  • CRISPR-Cas9 knock-in of epitope tags for improved antibody detection of Sur7 variants

  • Base editing to introduce point mutations in SUR7 to analyze structure-function relationships

  • Prime editing for precise modifications of SUR7 regulatory elements

• Single-cell technologies:

  • Single-cell proteomics to analyze Sur7 levels and modifications across heterogeneous populations

  • Spatial transcriptomics to correlate Sur7 protein localization with local gene expression patterns

  • Microfluidic approaches for tracking Sur7 dynamics during cellular decision-making processes

These technologies will enable researchers to move beyond static analysis of Sur7 localization to understand the dynamic regulation of this protein and its impact on PI4,5P2 distribution, septin recruitment, and ultimately fungal virulence mechanisms.

How might SUR7 antibody research contribute to antifungal drug development?

SUR7 antibody research has significant potential to contribute to antifungal drug development through several pathways:

• Target validation approaches:

  • Use SUR7 antibody to confirm accessibility of Sur7 protein domains in intact cells

  • Apply antibody competition assays to screen for small molecules that bind similar epitopes

  • Develop proximity-based assays with SUR7 antibody to identify compounds that disrupt critical protein interactions

• Mechanistic studies for drug mode-of-action:

  • Employ SUR7 antibody to monitor protein redistribution following drug treatment

  • Investigate whether antifungal candidates affect Sur7-dependent processes like PI4,5P2 regulation

  • Use SUR7 antibody to assess whether drug resistance mechanisms involve Sur7 pathway alterations

• Biomarker development:

  • Develop SUR7 antibody-based assays to monitor drug efficacy in clinical samples

  • Assess whether Sur7 levels or localization correlate with antifungal susceptibility

  • Create diagnostic tests based on Sur7 detection for fungal identification

• Novel therapeutic strategies:

  • Explore immunotherapeutic approaches targeting Sur7 exposed domains

  • Develop antibody-drug conjugates targeting Sur7 for targeted delivery

  • Design screening platforms to identify compounds that normalize PI4,5P2 distribution in sur7Δ mutants

Sur7's critical roles in cell wall morphogenesis, stress resistance, and PI4,5P2 regulation make it an attractive target for antifungal development . Since Sur7 regulates fundamental processes required for C. albicans virulence, compounds that mimic Sur7 function or compensate for its absence might represent novel therapeutic strategies against this important human pathogen.